Organizer: Bioprocess Online
-
Process Control’s Increasing Role in Biosimilar Approval
Regulators are shifting comparability expectations from large clinical trials to deep process understanding. Defining and controlling CPPs is now critical to proving biosimilarity. Join Bioprocess Online’s Jon O’Connell and industry experts for a virtual Q&A on applying QbD and reference product CQA insights to accelerate regulatory approval.